Replies to post #487 on Immunomedics Inc fka IMMU

[Ganz]

Article released 5 days ago.
In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Immunomedics, with a price target of $54.00. The company’s shares closed last Wednesday at $32.20, close to its 52-week high of $33.03.